News

20/01/2015 Slim MED FORTE is now registered in Kuwait as a Medical Device

After a long process, our well known Slim MEDTM FORTE has been authorized as Medical Device on the territory of Kuwait.

This registration is a pride for Al-Sayer Medical, our partner in Kuwait, and KitoZyme.

 

Find out more about Slim MEDTM  FORTE here or visit us on
Arab Health from 26th to 29th January in Dubaï,
booth Z2A10 (Belgian Pavilion)
to discover Slim MEDTM FORTE and
our NEW product Ki
OslimTM Double Action

14/01/2015 Press release : KitoZyme termine 2014 en beauté et affiche ses objectifs pour 2015

Herstal, Belgique – 14 Janvier 2015

 

2014 : Une année en forte croissance
2015 : KitoZyme affiche ses ambitions internationales.
           Développements dans les pays du Golfe :
           Koweït, Qatar et Emirats Arabes Unis.

 

L’année 2014 s’est terminée en beauté pour KitoZyme. «Les chiffres complets seront disponibles dans quelques semaines mais nous savons d’ores et déjà que l’année 2014 aura permis d’enregistrer une forte croissance des ventes de la société dans ses principaux segments d’activité. L’expansion commerciale s’est activement poursuivie tant en Europe qu’en Asie. C’est, en particulier, grâce à nos solutions innovantes de traitement de l’obésité et du surpoids que nous atteignons ces bons résultats », a commenté François Blondel, CEO et Administrateur délégué.

En confirmation de cette belle évolution, la société a en fin d’année remporté, dans sa catégorie (Technology – MedTech), le prix « DELOITTE – Fast 50 », récompensant parmi plusieurs centaines d’entreprises belges celle qui a connu la plus forte croissance.

 

2015 s’annonce riche en nouveautés pour KitoZyme

 

En 2015, la société, spin-off de l’université de Liège, élargira sa gamme de produits avec la mise sur le marché prévue de trois nouveaux compléments alimentaires et/ou dispositifs médicaux pour lesquels elle a d’ores et déjà reçu les approbations des différentes autorités règlementaires aux Etats-Unis ou en Europe. Ces produits sont destinés aux segments de la santé digestive (KiOfiber), de la gestion du poids (KiOslim Double Action) et de la santé cardiovasculaire (KiOcardio).

Sur le plan commercial, KitoZyme poursuivra son expansion géographique en dehors de l’Europe. Elle enregistrera notamment ses premières ventes dans plusieurs pays du Golfe (Koweït, Qatar et  Emirats Arabes Unis) en commercialisant pour la première fois des produits sous sa marque propre, dans le segment de la gestion du poids. La taille de ce marché potentiel pour l’entreprise excède 15 millions de personnes. Afin de soutenir cet important développement stratégique, l’entreprise participera notamment à la mission princière au Qatar prévue en mars de cette année.

Sur base d’une étude récente et des derniers chiffres publiés par l’OMS (Organisation Mondiale de la Santé), le Proche et Moyen-Orient sont particulièrement touchés par les problèmes liés au surpoids. Plus d’un tiers des habitants sont concernés. Ceci est principalement dû à une nutrition riche en énergie par volume, un manque d’aliments végétaux et un manque d’exercices physiques lié aux conditions climatiques difficiles (températures élevées). 

 

Fin du comuniqué 

13/01/2015 KiOslim Double Action: the NEW and unique product to discover on Arab Health

Don't miss the opportunity to discover our 
new slimming product on Arab Health (Dubaï) 
from 26 to 29th January on booth Z2A10 (Belgian Pavilion)

 

KiOslimTM Double Action is coming from a NEW and unique technology based on patented ingredients to help with treatment of excess weight: 

  • Improves the satiation feeling during a meal and prevents cravings
  • Binds at least 800 times its own weight in fat 

 

For more information or to arrange an appointment with our commercial team on Arab Health, contact us

 

 KiOslim Double Action  

 

    19/11/2014 Discover our NEW powerful product on HIE: KioSlim Double Action !

    KioSlimTM Double Action is a NEW medical device intended to
    treat excess weight with a superior technology.

     

    It helps with weight loss by: 

    improving the satiation feeling during a meal

    preventing cravings between two meals

    binding at least 800 times its own weight in fat

     

    KioSlimTM Double Action is avalaible in boxes of 60 capsules or 30 sticks 

     

    Keen to know more about KioSlimTM Double Action?

     

    • Visit us at Health Ingredient Europe at Amsterdam from 2nd to 4th December HALL 1 – BOOTH J6 (Awex’s Pavilion). 
    • Visit our KioSlimTM page 
    • Contact us 

     

     

     

     

     

     

     

    29/10/2014 KitoZyme won an Award at the Deloitte Technology Fast 50 competition

     

    Last week took place the ceremony of Deloitte Technology Fast 50 Awards.

    This competition rewards public or private companies headquartered in Belgium who develop a technology-related product or service and who have experienced substantial revenue growth over the last five years

    Hundreds of companies from all over Belgium were competing.

     

    It’s in this context that, with 1,144 percent growth in revenues, KitoZyme achieves the fastest growth in the Biotech, Nanotech & Medtech sector.

    This Award is an additional proof of the work done in research and development, production, regulatory, quality and marketing of KitoZyme products. A real honor for us.


      

    A new application of the concept

    Previously a Benelux competition, Fast 50 was, for the first year, organized only for Belgian companies.

    In this context of news, the number of award categories was expanded from the overall Fast50 and Rising Star categories, to include awards for the Most Sustainable Growth (selected from among the 2014 Fast50 contestants and Fast50 Alumni), Most Disruptive Innovator (selected from among the Rising Star contestants) and one winner from each of the following categories:

    1. IT & Digital Solutions

    2. Green Tech & Energy

    3. Biotech & Medical Technology

    4. Internet, Media & Telecom

     

    Global recognition

    The Belgian winners (Fast50 and Rising Star) automatically enter the Deloitte Technology Fast500 EMEA competition. With 25 participating countries, this competition ranks the 500 fastest-growing technology companies in Europe, the Middle East and Africa.

    Nikolaas Tahon, Managing Partner Accountancy: “Deloitte has a long-standing history of promoting innovation both within our firm and externally and we are pleased to highlight the achievements of all of the Belgian nominees. Once more, the huge and qualitative participation demonstrates the power of these technology companies in the Belgian economy.”

    “The Fast50 competition also provides a unique opportunity to build relationships amongst each other, as well as with venture capitalists and larger international companies, which can lead to international opportunities, and to enhance the company’s employer brand, helping to attract and retain talent.” explains Vincent Fosty, Partner and TMT Industry Leader.

           KitoZyme Deloitte technology Fast 50       

    24/09/2014 KitoZyme is nominated for Fast 50 !

     

    We are very proud to announce the nomination of KitoZyme to the “DELOITTE Technology Fast 50 ” prize!

     

    KitoZyme was selected amongst all public or private companies headquartered in Belgium who develop a technology-related product or service and who have experienced substantial revenue growth over the last five years.

     

    The award ceremony will be held on 22 October, 2014 in Brussels and is co-sponsored by Euronext and ING. 

     

    Keen to know more about Fast50? 

    kitozyme nomination Fast 50 deloitte

    25/06/2014 KitoZyme & Originates: the successful partnership !

    KitoZyme chose Originates, a global supplier of nutritional and functional ingredients for the supplement, food, cosmetic and pharmaceutical industries, as the exclusive partner in the American and Canadian markets.

    With the addition of KiOnutrime®-CsG (non-animal chitosan) and KiOnutrime®-CG (chitin-glucan) in its portfolio, Originates is now able to meet the needs of the nutraceutical and functional food market for high-quality ingredient that offer an array of health benefits to the end consumer.

    Sharing a common vision about human nutrition, we are sure that this partnership will be successful!

    Both companies will be present on SupplySide West from 06th to 10th October at Las Vegas.

    Feel free to contact us to arrange a meeting with our account manager: s.bologne@kitozyme.com

    29/04/2014 Visit us in Vitafoods and take home the best ideas

    Slim MED FORTE for weight management (non-animal chitosan)

    All the KitoZyme's team is happy to invite you to its booth number 22051 on the belgian pavilion at Vitafoods Europe from 6th to 8th May. 

    You will enjoy the presentation of the new utlimate fat binder: Slim MED™ FORTE!

    With its new formulation base on KiObind composed of Vitamin C and animal-free Chitosan, Slim MED™ FORTE is characterized by: 

    • An immediate action 
    • An optimal effect

    Keen to know more? Feel free to contact us to arrange a convenient meeting time.